selecting a pharmacokinetic model for patient dosing via output from a clinical decision matrix-1

FEATURED

Choosing the right model for your patient: An introduction to InsightRX Gemini

Resources
Scientific Publications
  • Oct 9, 2024

    • Impacts of age and BMI on vancomycin model choice in a Bayesian software: Lessons from a very large multi-site retrospective study

    Scientific Publications
  • May 21, 2024

    • Developing Parametric and Nonparametric Models for Model-Informed Precision Dosing: A Quality Improvement Effort in Vancomycin for Patients With Obesity

    Scientific Publications
  • Mar 26, 2024

    • Personalized Antifungal Therapy Through Model-Informed Precision Dosing of Posaconazole

    Scientific Publications
  • Mar 24, 2024

    • Maximum a posteriori Bayesian methods out-perform non-compartmental analysis for busulfan precision dosing

    Scientific Publications
  • Mar 15, 2024

    • Performance of Eight Infliximab Population Pharmacokinetic Models in a Cohort of Dutch Children with Inflammatory Bowel Disease

    Scientific Publications
  • Aug 10, 2023

    • Clinical decision support for chemotherapy-induced neutropenia using a hybrid pharmacodynamic/machine learning model

    Scientific Publications
  • Mar 8, 2023

    • Evaluating and Improving Neonatal Gentamicin Pharmacokinetic Models Using Aggregated Routine Clinical Care Data

    Scientific Publications
  • Mar 8, 2023

    • Prospective Validation and Refinement of a Population Pharmacokinetic Model of Fludarabine in Children and Young Adults Undergoing Hematopoietic Cell Transplantation

    Scientific Publications
  • Mar 8, 2023

    • Evaluation of Neonatal and Paediatric Vancomycin Pharmacokinetic Models and the Impact of Maturation and Serum Creatinine Covariates in a Large Multicentre Data Set